LFSC holdings
All 40 positions of F/m Emerald Life Sciences Innovation ETF.
Positions
40
Top 10 weight
54.7%
Effective holdings
23.9
1 / sum of squared weights
In stocks
99.0%
In bonds
0.0%
Outside the US
8.1%
Asset mix
Sectors
92% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | TVTXTravere Therapeutics, Inc. Common Stock | Equity | 7.67% | $8.1M | 170,714 | US |
| 2 | COGTCogent Biosciences, Inc. Common Stock | Equity | 7.53% | $7.9M | 226,142 | US |
| 3 | LivaNova PLC | Equity | 7.11% | $7.5M | 101,212 | GB |
| 4 | SYRESpyre Therapeutics, Inc. Common Stock | Equity | 6.41% | $6.7M | 91,588 | US |
| 5 | GHGuardant Health, Inc. Common Stock | Equity | 5.52% | $5.8M | 44,694 | US |
| 6 | MIRMMirum Pharmaceuticals, Inc. Common Stock | Equity | 4.92% | $5.2M | 50,911 | US |
| 7 | CORTCorcept Therapeutics Inc. | Equity | 4.79% | $5.0M | 72,454 | US |
| 8 | UTHRUnited Therapeutics Corp | Equity | 4.16% | $4.4M | 7,841 | US |
| 9 | MANEVeradermics, Incorporated | Equity | 3.42% | $3.6M | 35,568 | US |
| 10 | SVRASavara Inc. | Equity | 3.22% | $3.4M | 651,024 | US |
| 11 | CYTKCytokinetics Inc. | Equity | 3.16% | $3.3M | 43,268 | US |
| 12 | NKTRNektar Therapeutics | Equity | 3.14% | $3.3M | 50,876 | US |
| 13 | TRVITrevi Therapeutics, Inc. Common Stock | Equity | 3.12% | $3.3M | 231,602 | US |
| 14 | DNTHDianthus Therapeutics, Inc. Common Stock | Equity | 3.09% | $3.2M | 34,884 | US |
| 15 | AXSMAxsome Therapeutics, Inc | Equity | 2.84% | $3.0M | 12,723 | US |
| 16 | BLLNBillionToOne, Inc. Class A Common Stock | Equity | 2.73% | $2.9M | 29,023 | US |
| 17 | TMDXTransMedics Group, Inc. Common Stock | Equity | 2.68% | $2.8M | 41,894 | US |
| 18 | VRDNViridian Therapeutics, Inc. Common Stock | Equity | 2.23% | $2.3M | 133,261 | US |
| 19 | ICUIICU Medical Inc | Equity | 2.09% | $2.2M | 16,227 | US |
| 20 | CRVSCorvus Pharmaceuticals, Inc. | Equity | 1.95% | $2.1M | 165,305 | US |
| 21 | PVLAPalvella Therapeutics, Inc. Common Stock | Equity | 1.95% | $2.0M | 17,254 | US |
| 22 | CBLLCeriBell, Inc. Common Stock | Equity | 1.55% | $1.6M | 88,354 | US |
| 23 | GMEDGLOBUS MEDICAL INC | Equity | 1.27% | $1.3M | 16,258 | US |
| 24 | XERSXeris Biopharma Holdings, Inc. Common Stock | Equity | 1.22% | $1.3M | 207,543 | US |
| 25 | BBIOBridgeBio Pharma, Inc. Common Stock | Equity | 1.17% | $1.2M | 18,534 | US |
| 26 | ITGRInteger Holdings Corporation | Equity | 1.14% | $1.2M | 13,436 | US |
| 27 | TWSTTwist Bioscience Corporation Common Stock | Equity | 1.14% | $1.2M | 17,850 | US |
| 28 | RBILF/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF | Fund | 1.08% | $1.1M | 22,751 | US |
| 29 | WAYWaystar Holding Corp. Common Stock | Equity | 1.05% | $1.1M | 55,155 | US |
| 30 | WaVe Life Sciences Ltd | Equity | 0.95% | $1.0M | 152,008 | SG |
| 31 | HNGEHinge Health, Inc. | Equity | 0.94% | $989K | 17,590 | US |
| 32 | KRROKorro Bio, Inc. Common Stock | Equity | 0.80% | $843K | 62,855 | US |
| 33 | RDNTRadNet, Inc. Common Stock | Equity | 0.79% | $827K | 14,899 | US |
| 34 | AVAHAveanna Healthcare Holdings Inc. Common Stock | Equity | 0.72% | $758K | 105,779 | US |
| 35 | LMRILumexa Imaging Holdings, Inc. Common Stock | Equity | 0.70% | $739K | 94,977 | US |
| 36 | INSMInsmed, Inc. | Equity | 0.62% | $647K | 6,050 | US |
| 37 | ATECAlphatec Holdings, Inc. | Equity | 0.57% | $600K | 77,386 | US |
| 38 | NEONeoGenomics, Inc. | Equity | 0.43% | $453K | 43,071 | US |
| 39 | ALMRAlamar Biosciences, Inc. Common Stock | Equity | 0.18% | $193K | 9,442 | US |
| 40 | U.S. Bank Money Market Deposit Account | Cash | 0.00% | $203 | 203 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | KALVKalVista Pharmaceuticals Inc | 3.81% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | MANEVeraDermics Inc | — | 3.42% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CORTCorcept Therapeutics Inc | 1.52% | 4.79% | +75.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | WaVe Life Sciences Ltd | 4.21% | 0.95% | −48.2% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | DNTHDianthus Therapeutics Inc | — | 3.09% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TVTXTravere Therapeutics Inc | 4.63% | 7.67% | +13.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TMDXTransMedics Group Inc | 5.26% | 2.68% | +19.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ACADACADIA Pharmaceuticals Inc | 2.44% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | VRDNViridian Therapeutics Inc | — | 2.23% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | COLLCollegium Pharmaceutical Inc | 2.06% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | PVLAPalvella Therapeutics Inc | — | 1.95% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CYTKCytokinetics Inc | 1.38% | 3.16% | +100.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | MDGLMadrigal Pharmaceuticals Inc | 1.76% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BLLNBilliontoone Inc | 1.33% | 2.73% | +71.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | BBIOBridgebio Pharma Inc | 2.56% | 1.17% | −50.5% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | TWSTTwist Bioscience Corp | — | 1.14% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | SLNOSoleno Therapeutics Inc | 1.06% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ITGRInteger Holdings Corp | 2.18% | 1.14% | −45.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CRVSCorvus Pharmaceuticals Inc | 1.00% | 1.95% | +210.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ICUIICU Medical Inc | 3.03% | 2.09% | −16.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | XBILF/m US Treasury 6 Month Bill E | 0.66% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RBILF/m Ultrashort Treasury Inflat | 0.56% | 1.08% | +109.0% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | ALMRAlamar Biosciences Inc | — | 0.18% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | HNGEHinge Health Inc | 1.07% | 0.94% | −27.3% | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.